Hodak’s career trajectory reflects a singular obsession with the friction between human intent and machine execution. After co-founding Neuralink in 2016, he launched Science Corporation in 2021 to push neural engineering beyond simple novelty. The firm is already moving past theoretical frameworks; its PRIMA implant, which utilizes a retinal chip and camera-equipped glasses, has demonstrated success in restoring vision for patients with severe impairments. With $230 million in Series C funding and a valuation of $1.5 billion, the company is now eyeing broader therapeutic horizons, including seizure monitoring and potential treatments for Parkinson’s disease.
In section Startups & Technology
Max Hodak Wants to Delete the Screen
The keyboard and the glowing rectangle are becoming relics of the past. At TechCrunch Disrupt 2026, Science Corporation CEO Max Hodak is set to argue that the next generation of human-machine interaction will bypass traditional peripherals entirely, relying instead on direct neural links to reshape how we engage with technology.
At the upcoming Disrupt event in San Francisco, Hodak will detail how biohybrid interfaces might soon replace our reliance on screens. By integrating sensors directly into neural pathways, Science Corp aims to move toward a future where the machine adapts to the user’s biology rather than the other way around. Attendees at the Moscone West gathering will gain insight into how these advancements could disrupt current tech ecosystems and redefine the boundaries of human cognition.
Comments (0)
No comments yet. Be the first!